Insider Buying: Quoin Pharmaceuticals (NASDAQ:QNRX) CEO Buys 20,490 Shares of Stock
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Quoin Pharmaceuticals (NASDAQ:QNRX) CEO Michael Myers Purchases 20,490 Shares of Stock
Quoin Pharmaceuticals, Ltd. Sponsored ADR (NASDAQ:QNRX - Get Free Report) CEO Michael Myers acquired 20,490 shares of Quoin Pharmaceuticals stock in a transaction dated Monday, August 31st. The shares were bought at an average price of $4.88 per share, with a total value of $99,991.20. Following the transaction, the chief executive officer directly owned 37,713 shares in the company, valued at approximately $184,039.44. The trade was a 118.97% i…
Insider Buying: Quoin Pharmaceuticals (NASDAQ:QNRX) CEO Buys 20,490 Shares of Stock
Quoin Pharmaceuticals, Ltd. Sponsored ADR (NASDAQ:QNRX – Get Free Report) CEO Michael Myers purchased 20,490 shares of the stock in a transaction on Monday, August 31st. The stock was acquired at an average price of $4.88 per share, with a total value of $99,991.20. Following the acquisition, the chief executive officer directly owned 37,713 shares […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
